The move means 189 workers will lose their jobs at the cardboard recycling mill.
Industry
The New York holding group that bought the Minneapolis company in 2022 says it will "reflect and redefine" mission and products.
Nonprofit manufacturer BioMADE says the 122,000-square-foot plant will enable other businesses to test and develop novel technologies derived from living things.
The Democrat, who has voted for GOP initiatives, is likely to move to the left to take on Peggy Flanagan and Melisa López Franzen.
Latest Articles
The Democrat, who has voted for GOP initiatives, is likely to move to the left to take on Peggy Flanagan and Melisa López Franzen.
The former Medtronic CEO’s family foundation has already donated to Harvard in the past, but opted to accelerate its giving timeline in the face of federal funding cuts.
From the University of Maine, Volin gels with the college’s focus on a ‘holistic’ student experience.
St. Paul is increasingly disinclined to copy Minneapolis' prohibition.
The new six-month program is designed to get donors engaged in giving.
A weekend sweating with celebrity entrepreneur Jesse Itzler is good for business.
Here’s a simple way to understand angel investments (for folks over 30, at least).
From an intern to the new CEO, Nelson plans to build on the cooperative’s momentum in her new role.
Despite new economic uncertainties, a Padilla survey shows executives are eager to focus on long-term business strategies.
U.S. Rep. Kelly Morrison visits Beth Benike at Oronoco-based Busy Baby and calls for immediate tariff relief for small businesses.
IV Media’s next round of layoffs, impacting 72 workers, begins June 16
HR expert: Pay transparency poses challenges in assessing compensation for new and existing employees.
The Robbinsdale-based restaurant group, once known for inventive one-offs and pop-ups, is moving into acquisition and replication.
The Woodbury floral designer is Art in Bloom’s featured speaker this year at Mia, and her lecture will dig into creative authenticity.
Minnesota’s attorney general says that Surmodics’ plan to get acquired by a Chicago-based private equity firm is “anticompetitive.”